文献速递肝病消化道肿瘤与早癌

小鼠肝细胞中删除β-连环蛋白降解结构域驱动肝细胞癌或肝母细胞瘤样肿瘤生长

Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth.
PubMed 文献 · J Hepatol · 2022-03-04

研究通过肝细胞特异性诱导小鼠模型,比较CTNNB1外显子3缺失(βcatΔex3)与Apc外显子15移码(Apcfs-ex15)所致肝肿瘤。两种模型均产生分化或未分化肿瘤;分化型与人CTNNB1突变高分化肝细胞癌转录相似,未分化型与人间叶型肝母细胞瘤相似并伴YAP信号激活。

要点

  • βcatΔex3与Apcfs-ex15小鼠模型产生的肝肿瘤在表型上无法区分。
  • 分化型小鼠肿瘤与人CTNNB1突变高分化肝细胞癌聚类相似。
  • 未分化型小鼠肿瘤与人间叶型肝母细胞瘤聚类相似并伴YAP信号激活。

核心结论

  • Apcfs-ex15与βcatΔex3小鼠模型均诱导出转录水平类似人高分化β-连环蛋白激活肝细胞癌或间叶型肝母细胞瘤的肿瘤。

研究设计与样本

  • 使用Cre-Lox或CRISPR/Cas9经腺相关病毒载体构建的肝细胞特异性诱导小鼠模型。
  • Cre-Lox模型肿瘤经免疫组化表型分析并选取行RNA测序转录组分析。
  • 小鼠RNAseq数据与人RNAseq数据(8例正常组织、48例肝细胞癌、9例肝母细胞瘤)进行整合分析。
  • CRISPR模型肿瘤经DNA测序和免疫组化分析。

主要发现

  • 肝细胞CTNNB1外显子3缺失小鼠产生的肝肿瘤与Apcfs-ex15肝肿瘤无法区分。
  • Apcfs-ex15和βcatΔex3小鼠模型均诱导产生表型不同的肿瘤(分化型或未分化型)。
  • 整合分析显示分化型小鼠肿瘤与人CTNNB1突变高分化肿瘤聚类。
  • 未分化型小鼠肿瘤与人间叶型肝母细胞瘤聚类并伴YAP信号激活。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: One-third of hepatocellular carcinomas (HCCs) harbor mutations activating the β-catenin pathway, predominantly via mutations in the CTNNB1 gene itself. Mouse models of Apc loss-of-function are widely used to mimic β-catenin-dependent tumorigenesis. Given the low prevalence of APC mutations in human HCCs, we aimed to generate liver tumors through CTNNB1 exon 3 deletion (βcatΔex3). We then compared βcatΔex3 liver tumors with liver tumors generated via frameshift in exon 15 of Apc (Apcfs-ex15). METHODS: We used hepatocyte-specific and inducible mouse models generated through either a Cre-Lox or a CRISPR/Cas9 approach using adeno-associated virus vectors. Tumors generated by the Cre-Lox models were phenotypically analyzed using immunohistochemistry and were selected for transcriptomic analysis by RNA-sequencing (RNAseq). Mouse RNAseq data were compared to human RNAseq data (8 normal tissues, 48 HCCs, 9 hepatoblastomas) in an integrative analysis. Tumors generated via CRISPR were analyzed using DNA sequencing and immuno-histochemistry. RESULTS: Mice with CTNNB1 exon 3 deletion in hepatocytes developed liver tumors indistinguishable from Apcfs-ex15 liver tumors. Both Apcfs-ex15 and βcatΔex3 mouse models induced growth of phenotypically distinct tumors (differentiated or undifferentiated). Integrative analysis of human and mouse tumors showed that differentiated mouse tumors cluster with well-differentiated human CTNNB1-mutated tumors. Conversely, undifferentiated mouse tumors cluster with human mesenchymal hepatoblastomas and harbor activated YAP signaling. CONCLUSION: Apcfs-ex15 and βcatΔex3 mouse models both induce growth of tumors that are transcriptionally similar to either well-differentiated and β-catenin-activated human HCCs or mesenchymal hepatoblastomas. LAY SUMMARY: New and easy-to-use transgenic mouse models of primary liver cancers have been generated, with mutations in the gene encoding beta-catenin, which are frequent in both adult and pediatric primary liver cancers. The mice develop both types of cancer, constituting a strong preclinical model.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Loesch R, Caruso S, Paradis V, et al. Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth. J Hepatol. 2022. PMID: 35257829. doi:10.1016/j.jhep.2022.02.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。